4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-21-039917
Chief Financial Officer disposed of 7,500 shares (other)
- Chief Financial Officer gave up 1,067 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2021-03-17 | Shares withheld for taxes | −1,067 | $3.22 | $3,436 | 19,220 | D |
| Bonner Michael Chief Financial Officer | 2021-05-17 | Other disposition | −7,500 | $2.83 | $21,225 | 11,720 | D |
| Derivatives | |||||||
| Bonner Michael Chief Financial Officer | 2021-03-17 | Grant or award · Options (right to buy) | +5,000 | 5,000 | D | ||
| Bonner Michael Chief Financial Officer | 2021-05-17 | Returned to the company · Options (right to buy) | −5,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…